BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 35642928)

  • 21. Alterations in fecal virome and bacteriome virome interplay in children with autism spectrum disorder.
    Wan Y; Zhang L; Xu Z; Su Q; Leung TF; Chan D; Wong OWH; Chan S; Chan FKL; Tun HM; Ng SC
    Cell Rep Med; 2024 Feb; 5(2):101409. PubMed ID: 38307030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fecal virome transplantation is sufficient to alter fecal microbiota and drive lean and obese body phenotypes in mice.
    Borin JM; Liu R; Wang Y; Wu TC; Chopyk J; Huang L; Kuo P; Ghose C; Meyer JR; Tu XM; Schnabl B; Pride DT
    Gut Microbes; 2023; 15(1):2236750. PubMed ID: 37475473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stable core virome despite variable microbiome after fecal transfer.
    Broecker F; Russo G; Klumpp J; Moelling K
    Gut Microbes; 2017 May; 8(3):214-220. PubMed ID: 27935413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterizations of the Gut Bacteriome, Mycobiome, and Virome in Patients with Osteoarthritis.
    Chen C; Zhang Y; Yao X; Li S; Wang G; Huang Y; Yang Y; Zhang A; Liu C; Zhu D; Li H; Yan Q; Ma W
    Microbiol Spectr; 2023 Feb; 11(1):e0171122. PubMed ID: 36515546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of fecal microbiota transplantation and fecal virome transplantation on LPS-induced intestinal injury in broilers.
    Wu D; Liang S; Du X; Xiao J; Feng H; Ren Z; Yang X; Yang X
    Poult Sci; 2024 Feb; 103(2):103316. PubMed ID: 38128454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacteriophage-mediated manipulation of the gut microbiome - promises and presents limitations.
    Rasmussen TS; Koefoed AK; Jakobsen RR; Deng L; Castro-Mejía JL; Brunse A; Neve H; Vogensen FK; Nielsen DS
    FEMS Microbiol Rev; 2020 Jul; 44(4):507-521. PubMed ID: 32495834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transplanting Fecal Virus-Like Particles Reduces High-Fat Diet-Induced Small Intestinal Bacterial Overgrowth in Mice.
    Lin DM; Koskella B; Ritz NL; Lin D; Carroll-Portillo A; Lin HC
    Front Cell Infect Microbiol; 2019; 9():348. PubMed ID: 31750259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Faecal microbiota transplantation reduces amounts of antibiotic resistance genes in patients with multidrug-resistant organisms.
    Hyun J; Lee SK; Cheon JH; Yong DE; Koh H; Kang YK; Kim MH; Sohn Y; Cho Y; Baek YJ; Kim JH; Ahn JY; Jeong SJ; Yeom JS; Choi JY
    Antimicrob Resist Infect Control; 2022 Jan; 11(1):20. PubMed ID: 35093183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beyond faecal microbiota transplantation, the non-negligible role of faecal virome or bacteriophage transplantation.
    Wu D; Zhang C; Liu Y; Yao J; Yang X; Wu S; Du J; Yang X
    J Microbiol Immunol Infect; 2023 Oct; 56(5):893-908. PubMed ID: 36890066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal microbiota transplantation as therapy for recurrent Clostridioides difficile infection is associated with amelioration of delirium and accompanied by changes in fecal microbiota and the metabolome.
    Gotoh K; Sakaguchi Y; Kato H; Osaki H; Jodai Y; Wakuda M; Také A; Hayashi S; Morita E; Sugie T; Ito Y; Ohmiya N
    Anaerobe; 2022 Feb; 73():102502. PubMed ID: 34896553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metagenomic Characterization of Gut Microbiota of Carriers of Extended-Spectrum Beta-Lactamase or Carbapenemase-Producing Enterobacteriaceae Following Treatment with Oral Antibiotics and Fecal Microbiota Transplantation: Results from a Multicenter Randomized Trial.
    Leo S; Lazarevic V; Girard M; Gaïa N; Schrenzel J; de Lastours V; Fantin B; Bonten M; Carmeli Y; Rondinaud E; Harbarth S; Huttner BD
    Microorganisms; 2020 Jun; 8(6):. PubMed ID: 32585945
    [No Abstract]   [Full Text] [Related]  

  • 32. Fecal Microbiota Transplantation as an Effective Treatment for Carbapenem-Resistant
    Wang J; Li X; Wu X; Wang Z; Wu X; Wang S; Jing G; Yan T
    Infect Drug Resist; 2021; 14():1805-1811. PubMed ID: 34017186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut bacteriophage dynamics during fecal microbial transplantation in subjects with metabolic syndrome.
    Manrique P; Zhu Y; van der Oost J; Herrema H; Nieuwdorp M; de Vos WM; Young M
    Gut Microbes; 2021; 13(1):1-15. PubMed ID: 33794724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease Prevention Not Decolonization: A Model for Fecal Microbiota Transplantation in Patients Colonized With Multidrug-resistant Organisms.
    Ghani R; Mullish BH; McDonald JAK; Ghazy A; Williams HRT; Brannigan ET; Mookerjee S; Satta G; Gilchrist M; Duncan N; Corbett R; Innes AJ; Pavlů J; Thursz MR; Davies F; Marchesi JR
    Clin Infect Dis; 2021 Apr; 72(8):1444-1447. PubMed ID: 32681643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Features of the gut prokaryotic virome of Japanese patients with Crohn's disease.
    Imai T; Inoue R; Nishida A; Yokota Y; Morishima S; Kawahara M; Kusada H; Tamaki H; Andoh A
    J Gastroenterol; 2022 Aug; 57(8):559-570. PubMed ID: 35689701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement.
    Woodworth MH; Conrad RE; Haldopoulos M; Pouch SM; Babiker A; Mehta AK; Sitchenko KL; Wang CH; Strudwick A; Ingersoll JM; Philippe C; Lohsen S; Kocaman K; Lindner BG; Hatt JK; Jones RM; Miller C; Neish AS; Friedman-Moraco R; Karadkhele G; Liu KH; Jones DP; Mehta CC; Ziegler TR; Weiss DS; Larsen CP; Konstantinidis KT; Kraft CS
    Sci Transl Med; 2023 Nov; 15(720):eabo2750. PubMed ID: 37910603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplantation of bacteriophages from ulcerative colitis patients shifts the gut bacteriome and exacerbates the severity of DSS colitis.
    Sinha A; Li Y; Mirzaei MK; Shamash M; Samadfam R; King IL; Maurice CF
    Microbiome; 2022 Jul; 10(1):105. PubMed ID: 35799219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging applications of phage therapy and fecal virome transplantation for treatment of Clostridioides difficile infection: challenges and perspectives.
    Raeisi H; Noori M; Azimirad M; Mohebbi SR; Asadzadeh Aghdaei H; Yadegar A; Zali MR
    Gut Pathog; 2023 May; 15(1):21. PubMed ID: 37161478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Bacterial and Fungal Dynamics following Oral Lyophilized Fecal Microbiota Transplantation in Clostridioides difficile Infection.
    Haifer C; Paramsothy S; Borody TJ; Clancy A; Leong RW; Kaakoush NO
    mSystems; 2021 Feb; 6(1):. PubMed ID: 33531405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Human Gut Virome and Its Relationship with Nontransmissible Chronic Diseases.
    Ezzatpour S; Mondragon Portocarrero ADC; Cardelle-Cobas A; Lamas A; López-Santamarina A; Miranda JM; Aguilar HC
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.